NPCE
NeuroPace·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NPCE fundamentals
NeuroPace (NPCE) released its earnings on Nov 4, 2025: revenue was 27.40M (YoY +30.10%), beat estimates; EPS was -0.11 (YoY +42.11%), beat estimates.
Revenue / YoY
27.40M
+30.10%
EPS / YoY
-0.11
+42.11%
Report date
Nov 4, 2025
NPCE Earnings Call Summary for Q3,2025
- Revenue Beat: Q3 $27.4M (+30% YoY), RNS up 31% to $22.6M, DIX Milestone**: First positive EBITDA, grossI winding down.
- **Margin margin 77.4% (vs 73.2% YoY), 2025 guide 76-77%.
- Pipeline Catalysts: NAUTILUS PMA Q4, pediatric PMA via real-world evidence, Seizure ID FDA submission.
- Growth Drivers: 20%+ RNS core, growth AI tools, and expanding into Level 3/Community centers.
- Operational Strength: $60M cash, 21% opex vs 30% rev, disciplined expense mgmt.
EPS
Revenue
Revenue & Expenses
NPCE has released its 2025 Q3 earnings report, with revenue of 27.35M, reflecting a YoY change of 29.89%, and net profit of -3.50M, showing a YoY change of 35.88%. The Sankey diagram below clearly presents NPCE's revenue sources and cost distribution.
Key Indicators
NeuroPace (NPCE) key financial stats and ratios, covering profitability, financial health, and leverage.
NeuroPace (NPCE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
NeuroPace (NPCE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
NeuroPace (NPCE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does NeuroPace (NPCE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track NeuroPace (NPCE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for NeuroPace year over year?What factors drove the changes in NeuroPace's revenue and profit?What is NeuroPace's latest dividend and current dividend yield?Did NeuroPace beat or miss consensus estimates last quarter?What is the market's earnings forecast for NeuroPace next quarter?What guidance did NeuroPace's management provide for the next earnings period?What does NeuroPace do and what are its main business segments?What is NeuroPace's gross profit margin?
